A carregar...
Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
Background. Ivacaftor improves outcomes in cystic fibrosis (CF) patients with the G551D mutation; however, effects on respiratory microbiology are largely unknown. This study examines changes in CF respiratory pathogens with ivacaftor and correlates them with baseline characteristics and clinical re...
Na minha lista:
| Publicado no: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4342673/ https://ncbi.nlm.nih.gov/pubmed/25425629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu944 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|